Xenon Pharmaceuticals Inc.

Bank of New York Mellon Corp XENE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

387,158

Value ($000)

17,352

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	17,352	0.0%	387,158	12/31/2025
2025 Q3	11/3/2025	16,799	0.0%	418,416	9/30/2025
2025 Q2	8/5/2025	13,647	0.0%	436,020	6/30/2025
2025 Q1	4/29/2025	8,426	0.0%	251,147	3/31/2025
2024 Q4	2/4/2025	1,827	0.0%	46,597	12/31/2024
2024 Q3	11/12/2024	1,925	0.0%	48,891	9/30/2024
2024 Q2	7/25/2024	1,998	0.0%	51,254	6/30/2024
2024 Q1	4/25/2024	2,880	0.0%	66,910	3/31/2024
2023 Q4	1/29/2024	3,070	0.0%	66,659	12/31/2023
2023 Q3	10/24/2023	5,717	0.0%	167,349	9/30/2023
2023 Q2	8/3/2023	8,152	0.0%	211,741	6/30/2023
2023 Q1	5/9/2023	7,136	0.0%	199,387	3/31/2023
2022 Q4	2/14/2023	15,313	0.0%	388,360	12/31/2022
2022 Q3	11/14/2022	15,799	0.0%	437,645	9/30/2022
2022 Q2	8/15/2022	17,132	0.0%	563,187	6/30/2022
2022 Q1	5/11/2022	17,707	0.0%	579,208	3/31/2022
2021 Q4	2/11/2022	24,727	0.0%	791,525	12/31/2021
2021 Q3	11/18/2021	14,282	0.0%	934,643	9/30/2021
2021 Q2	8/11/2021	17,420	0.0%	935,542	6/30/2021
2021 Q1	5/13/2021	17,152	0.0%	958,153	3/31/2021
2020 Q4	2/9/2021	14,599	0.0%	949,238	12/31/2020
2020 Q3	11/12/2020	8,267	0.0%	746,803	9/30/2020
2020 Q2	8/12/2020	9,966	0.0%	794,689	6/30/2020
2020 Q1	5/6/2020	7,664	0.0%	675,876	3/31/2020
2019 Q4	2/14/2020	3,228	0.0%	246,263	12/31/2019